ORPHENADRINE CITRATE
- Product NDC
- 80425-0340
- 11-digit product format
- 804250340
- Labeler code
- 80425
- Product ID
- 80425-0340_2a9ba8f4-6cf3-e827-e063-6394a90a0300
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ORPHENADRINE CITRATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Application
- ANDA040284
- Marketing category
- ANDA
- Marketing start
- 2023-05-23
- Substance
- ORPHENADRINE CITRATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X0A40N8I4S | ORPHENADRINE CITRATE | 4682-36-4 | ORPHENADRINE CITRATE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 80425-0340-1 | 80425034001 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0340-1) | 2023-05-23 | No | No | Historical |
| 80425-0340-2 | 80425034002 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0340-2) | 2023-08-17 | No | No | Historical |